Position in PCVX
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$15,017,187
-$2,397,971 QoQ
Shares Held
258,338
-13.8% QoQ
Ownership
0.174%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#68
of 329 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 47%
Shared 0%
None 53%
Common Shares in PCVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DEUTSCHE BANK AG\ holds $3,190,028,280 across 296 Biotechnology names. PCVX ranks #29 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,579,110 | $784,391,303 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
518,409 | $323,248,743 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
815,400 | $245,459,858 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
888,019 | $166,308,196 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,717,951 | $152,395,510 | |
| 6 | INCY |
Incyte Corp
|
1,262,988 | $143,172,312 | |
| 7 | ARGX |
Argenx SE
|
137,335 | $127,415,291 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
249,611 | $78,899,539 |
All Filings in PCVX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,017,187 | 258,338 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $17,415,158 | 299,693 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $15,821,127 | 342,894 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $14,328,357 | 397,789 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $8,548,731 | 262,957 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $45,224,697 | 1,197,688 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $99,272,112 | 1,212,706 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $131,202,984 | 1,148,184 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $9,820,981 | 130,062 | Shares | Defined | 2025-06-12 | |
| 2024-03-31 | $9,300,269 | 136,148 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $9,561,801 | 152,258 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $3,827,527 | 75,079 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $2,146,420 | 42,980 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,856,346 | 49,529 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,701,984 | 35,495 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $571,848 | 23,827 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $576,443 | 26,491 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $586,506 | 24,286 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $714,745 | 30,044 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $727,509 | 28,676 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $668,658 | 29,705 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $378,409 | 19,160 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $366,186 | 13,782 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $480,812 | 9,737 | Shares | Defined | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||